September 26 2023 26 Sep 2023 Paris M&A: Implications of Foreign Direct Investment Control on Your Transactions See documents
September 27 2023 27 Sep 2023 Online Foreign Subsidies: Terms and Conditions of the FSR: Implementing Regulation, Q&A... See documents
September 27 2023 27 Sep 2023 Online Antitrust Compliance Insights from Saint-Gobain & Santander See documents
September 28 2023 28 Sep 2023 Brussels Global Antitrust Hot Topics: EU, US & Global Perspectives See documents
Gun jumping in mergers: An overview of EU and national case law New 21 September 2023 Adela Boitoș European Commission - Legal Service (Brussels) Belgium 1 contribution 1040 visits
The EU Commission issues a record-breaking €432M gun jumping fine on a biotech firm for its acquisition of a nascent (...) 12 July 2023 Catherine Gordley Van Bael & Bellis (Brussels) Belgium 38 contributions 9480 visits
The economics of new product launches and access to pharmaceutical products in the EU: A perspective on the EC’s (...) September 2023 Margaret Kyle MINES ParisTech (Paris) France 6 contributions 12361 visits , Sinan Corus Cornerstone Research (London) United Kingdom 2 contributions 2032 visits , Julia Tanndal Cornerstone Research (London) United Kingdom 1 contribution 938 visits
Is it the advent of fairness? September 2023 Marc Ivaldi Toulouse School of Economics France 7 contributions 3709 visits , Connie Lee NERA (Paris) France 1 contribution 756 visits
22 Sep 2023 The US DoJ announces the launch of a joint initiative to deter, detect and prosecute collusive schemes related to the (...) US Department of Justice Antitrust Division
18 Sep 2023 The UK Competition Authority publishes its initial report on the regulation of AI Christopher Peacock, Dan Whitehead, Angus Coulter, Eduardo Ustaran
16 Sep 2023 The US DOJ continues to ramp up enforcement against interlocking directorates in its latest move forcing two (...) Brian Burke, John Fedele, Mark Hamer, Teisha Johnson, Nandu Machiraju, Creighton Macy, Courtney DeVore, Daniel Graulich
14 Sep 2023 The US FTC issues a policy statement warning pharmaceuticals off improperly listing their drugs on the FDA’s "Orange (...) Julia Chapman, George Gordon, Katherine A. Helm, Robert Rhoad, Andrew Figueiredo
14 Sep 2023 The Canadian Prime Minister announces proposed changes to the national competition regime to combat inflation challenges Antonio Di Domenico, Christopher D. Margison, Robin Spillette
Sep 2023 Statement of Concerns regarding the jurisdictional issues arising in the European Commission’s position in relation to (...) Calvin Goldman, Frank Montag, John Pecman
Sep 2023 Patent hold-up and the pharmaceutical sector Walid Chaiehloudj, Marion Provost, Mélanie Thill-Tayara, Wladimir Soltmann, Elisabetta M. Lanza, Nicolas Binctin
Sep 2023 Damien Gerard (Belgian Competition Authority): For a rigorous and effective competition policy anchored in market realities Damien Gerard, Isabel Rooms
Sep 2023 Getting over market definition: The NVIDIA/Arm merger Thomas Bowman, Thibaut de Bernard, Guillaume Duquesne
Sep 2023 Are excessive pricing cases few and far between? A quantitative analysis of fifty years of European jurisprudence 1971–2021 Behrang Kianzad
